A neutralization site of DA strain of Theiler's murine encephalomyelitis virus important for disease phenotype

Virology

Volumn 226, Issue 2, 1996, Pages 327-337

  Sato, Shigeru ^a   Zhang, Liang ^a   Kim, Jong ^a   Jakob, John ^a   Grant, Robert A ^b   Wollmann, Robert ^a   Roos, Raymond P ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ARTICLE; DNA VIRUS; ENCEPHALOMYELITIS; MURINE ENCEPHALOMYELITIS VIRUS; MUTATION; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; VIROGENESIS;

EID: 0030589468     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0660     Document Type: Article

References (27)

1. Boege, U., Kobasa, D., Onodera, S., Parks, G. D., Palmenberg, A. C., and Scraba, D. G. (1991). Characterization of Mengo virus neutralization epitopes. Virology 181, 1-13.
2. Colston, E. M., and Racaniello, V. R. (1995). Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition. J. Virol. 69, 4823-4829.
3. Couderc, T., Guedo, N., Calvez, V., Pelletier, I., Hogle, J., Colbere-Garapin, R., and Blondel, B. (1994). Substitutions in the capsids of poliovirus mutants selected in human neuroblastoma cells confer on the Mahoney Type 1 strain a phenotype neurovirulent in mice. J. Virol. 68, 8386-8391.
4. Couderc, T., Martin, A., Wychowski, C., Girard, M., Horaud, F., and Crainic, R. (1991 ). Analysis of neutralization-escape mutants selected from a mouse virulent type 1/type 2 chimeric poliovirus: identification of a type 1 poliovirus with antigenic site 1 deleted. J Gen. Virol. 72, 973-977.
5. Fu, J., Stein, S., Rosenstein, L., Bodwell, T., Routbort, M., Semler, B. L., and Roos, R. P. (1990). Neurovirulence determinants of genetically engineered Theiler's viruses. Proc. Natl. Acad. Sci. USA 87, 4125-4129.
6. Grant, R. A., Filman, D. J., Fujinami, R. S., Icenogle, J. P., and Hogle, J. M. (1992). Three-dimensional structure of Theiler's virus. Proc. Natl. Acad. Sci. USA 89, 2061-2065.
7. Jarousse, N., Grant, R. A., Hogle, J. M., Zhang, L., Senkowski, A., Roos, R. P., Michiels, T., Brahic, M., and McAllister, A. (1994). A single amino acid change determines persistence of a chimeric Theiler's virus. J. Virol. 68, 3364-3368.
8. Li, Q., Gomez-Yafal, A., Lee, Y. M-H., Hogle, J., and Chow, M. (1994). Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature. J. Virol. 68, 3865-3970.
9. Lipton, H. L. (1975). Theiler's virus infection in mice: an unusual biphasic process leading to demyelination. Infect. Immun. 11, 1147-1155.
10. Lipton, H. L., and Dal Canto, M. C. (1978). The TO strains of Theiler's virus cause "slow virus-like" infection in mice. Ann. Neurol. 6, 25-28.
11. Luo, M., He, C., Toth, K. S., Zhang, C. X., and Lipton, H. L. (1992). Three-dimensional structure of Theiler murine encephalomyelitis virus (BeAn strain). Proc. Natl. Acad. Sci. USA 89, 2409-2413.
12. McAllister, A., Tangy, F., Aubert, C., and Brahic, M. (1989). Molecular cloning of the complete genome of Theiler's virus, strain DA, and production of infectious transcripts. Microb. Pathog. 7, 381-388.
13. Martin, A., Wychowski, C., Couderc, C., Crainic, R., Hogle, J., and Girard, M. (1991). Engineering a poliovirus type 2 antigenic site on a type 1 capsid to study determinants. EMBO J. 7, 2839-2847.
14. Murray, M. G., Bradley, J., Yang, X.-F., Wimmer, E., Moss, E. G., and Racaniello, V. R. (1988). Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site 1. Science 241, 213-215.
15. Nitayaphan, S., Toth, M., and Roos, R. P. (1985). Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis Virus. J. Virol. 53, 651-657.
16. Ohara, Y., Senkowski, A., Fu, J., Klaman, L., Goodall, J., Toth, M., and Roos, R. P. (1988). Trypsin-sensitive neutralization site on VP1 of Theiler's murine encephalomyelitis viruses. J. Virol. 62, 3527-3529.
17. Page, G. S., Mosser, A. G., Hogle, J. M., Filman, D. J., Rueckert, R. R., and Chow, M. (1988). Three-dimensional structure of poliovirus serotype I neutralizing determinants. J. Virol. 62, 1781-1794.
18. Pritchard, A. E., Jensen, K., and Lipton, H. L. (1993). Assembly of Theiler's virus recombinants used in mapping determinants of neurovirulence. J. Virol. 67, 3901-3907.
19. Reiner, S. L., Zheng, S., Cory, D. B., and Locksley, R. M. (1993). Constructing polycompetitor cDNAs for quantitative PCR J. Immunol. Methods 165, 37-46.
20. Roos, R. P., and Casteel, M. C. (1992). Determinants of neurological disease induced by Theiler's murine encephalomyelitis virus. In "Molecular Neurovirology: Pathogenesis of Central Nervous System Infections" (R. P. Roos, Ed.), pp. 283-318. Humana Press, Totowa, NJ.
21. Roos, R. P., Stein, S., Ohara, Y., Fu, J., and Semler, B. L. (1989a). Infectious cDNA clones of the DA strain of Theiler's murine encephalomyelitis virus. J. Virol. 63, 5492-5496.
22. Roos, R. P., Stein, S., Routbort, M., Senkowski, A., Bodwell, T., and Wollmann, R. (1989b). Theiler's murine encephalomyelitis virus neutralization escape mutants have a change in disease phenotype. J. Virol. 63, 4469-4473.
23. Tangy, F., McAllister, A., Aubert, C., and Brahic, M. (1991). Determinants of persistence of demyelination of the DA strain of Theiler's virus are found only in the VP1 gene. J. Virol. 65, 1616-1618. [Author's correction, 67, 2427, 1993.]
24. Tangy, F. A., McAllister, A., and Brahic, M. (1989). Molecular cloning of the complete genome of Theiler's virus, strain GDVII, and production of infectious transcripts. J. Virol. 63, 1101-1106.
25. Zhang, L., Sato, S., Kim, J. I., and Roos, R. P. (1995). Theiler's virus as a vector for foreign gene delivery. J. Virol. 69, 3171-3175.
26. Zhang, L., Senkowski, A., Shim, B., and Roos, R. P. (1993). Chimeric cDNA studies of Theiler's murine encephalomyelitis virus neurovirulence. J. Virol. 67, 4404-4408.
27. Zurbriggen, A., Thomas, C., Yamada, M., Roos, R. P., and Fujinami, R. S. (1991). Direct evidence of a role for amino acid 101 of VP-I in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J. Virol. 65, 1929-1937.